Norges Bank Investment Management »

Nurix Therapeutics shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 258k 10.32

More positions owned by Norges Bank Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Ubs Group SHS (UBS)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Norges Bank Investment Management

Top funds holding Nurix Therapeutics

Baker Bros. Advisors
Redmile Group
ARK Investment Management
Vanguard Group
T. Rowe Price Associates
Daniel D. Thurber
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Millennium Management
Bessemer
Arrowpoint Asset Management
Taddei, Ludwig & Associates
Goldman Sachs Group

View all funds holding Nurix Therapeutics